COR.NYSECencora, INC

Form 4: Cencora Executive Chairman Steven H. Collis Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Executive Chairman of Cencora, Steven H. Collis, reports the acquisition and disposal of company stock and restricted stock units.

Summary

  • Steven H. Collis, Executive Chairman of Cencora, filed a Form 4 detailing transactions involving company stock and restricted stock units.
  • On November 8, 2024, Collis acquired 11,936, 10,536, and 7,454 shares of common stock through the vesting of restricted stock units.
  • He also disposed of 5,191, 4,335, and 3,067 shares of common stock to cover tax obligations related to the vesting of these units at a price of $248.41 per share.
  • The transactions resulted in a net increase in his direct holdings of common stock and restricted stock units.
  • The restricted stock units vest in three equal annual installments.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The transactions are routine and expected, but the increase in holdings suggests confidence from the executive chairman.

Positives

  • The vesting of restricted stock units indicates that performance milestones have been met.
  • The executive chairman's increased holdings of common stock demonstrates confidence in the company's future.

Negatives

  • The disposal of shares to cover tax obligations, while standard, does reduce the overall increase in holdings.

Risks

  • There are no significant risks identified in this document.

Industry Context

This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the holdings of key executives.

Comparison to Industry Standards

  • Form 4 filings are standard practice for publicly traded companies in the US, and Cencora's filing is consistent with these requirements.
  • The vesting schedules for restricted stock units are typical for executive compensation packages in the pharmaceutical distribution industry.
  • Companies like McKesson and Cardinal Health also have similar insider transaction disclosures.

Stakeholder Impact

  • The transactions provide transparency to shareholders regarding executive holdings.
  • The vesting of restricted stock units may be seen positively by employees as it indicates the company is meeting performance targets.

Key Dates

DateDescription
11/08/2024Date of stock and restricted stock unit transactions.
11/10/2022First vesting date of some restricted stock units.
11/10/2023Second vesting date of some restricted stock units.
11/10/2024Third vesting date of some restricted stock units.
11/09/2023First vesting date of some restricted stock units.
11/09/2024Second vesting date of some restricted stock units.
11/09/2025Third vesting date of some restricted stock units.
11/08/2025Second vesting date of some restricted stock units.
11/08/2026Third vesting date of some restricted stock units.
11/13/2024Date of filing of the Form 4.

Keywords

Cencora, Steven H. Collis, Form 4, Stock Transactions, Restricted Stock Units, Executive Chairman, Insider Trading, Share Vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.